SRx Health Solutions Provides Response Related to Unusual Market Trading Activity Received by the NYSE American Exchange
Rhea-AI Summary
SRx Health Solutions (NYSE American: SRXH) said the NYSE American notified the company of unusual trading activity in its common shares on November 6, 2025. The company stated it is not aware of any material developments beyond what has been publicly disclosed and reminded investors to rely on its SEC filings and press releases. The release was issued pursuant to Section 401(d) of the NYSE American Company Guide and includes a standard forward-looking statements caution.
Contact information for CEO Kent Cunningham and investor relations via KCSA Strategic Communications is provided for further inquiries.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SRXH declined 6.72%, reflecting a notable negative market reaction. Argus tracked a peak move of +30.6% during that session. Argus tracked a trough of -26.3% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $714K from the company's valuation, bringing the market cap to $10M at that time. Trading volume was exceptionally heavy at 12.8x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the Company has been notified by the NYSE American of unusual trading activity of its Common Shares on November 6, 2025. The Company is not aware of any material developments in its business or affairs beyond those that have been publicly disclosed. Investors should rely solely on the Company’s filings with the SEC and its press releases.
The Company is issuing this press release pursuant to Section 401(d) of the NYSE American Company Guide.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
FAQ
What did SRx Health Solutions (SRXH) say about unusual trading on November 6, 2025?
Does SRx Health Solutions (SRXH) report any material developments after the unusual trading notice?
Where should investors look for official information about SRx Health Solutions (SRXH)?
Why did SRx Health Solutions (SRXH) issue this press release under NYSE rules?
Who can investors contact for more information about SRx Health Solutions (SRXH)?
